Radiation-induced cancers: A 1997 state of the art;Cancers radio-induits: Le point en 1997

Cancer/Radiotherapie

Volumn 1, Issue 6, 1997, Pages 823-835

  Cosset, J M ^a  

^a INSTITUT CURIE   (France)

Author keywords

LENT SOMA; Leukemia; Radiation induced neopla; Radiotheraphy adverse effects; Tchernobyl

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOGEN; RADIOACTIVE IODINE;

CANCER RISK; CHERNOBYL ACCIDENT; HUMAN; IONIZING RADIATION; NUCLEAR ACCIDENT; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION INJURY; REVIEW; THYROID CARCINOMA; TOBACCO;

EID: 0031417871     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(97)82964-2     Document Type: Article

References (87)

1. Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willet CG. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 1997; 79:1203-10
2. Andrieu JM, Ifrah N, Payen C. Increased risk of secondary acute non lymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease. J Clin Oncol 1990;8:1148-54
3. Arnstein A. Uber den sogenannten "Schneebergen Lungenkrebs". Verh Dtsch Ges Pathol 1913;16:332-42
4. Balyney DW, Longo DL, Young RC. Decreasing risk of leukaemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 1987; 316:710-4
5. Bard D, Laurier D, Tirmarche M, Verger P. Le suivi des survivants des bombardements de Hiroshima et Nagasaki. Principes, nouvelles publications et implications en radioprotection. Energies-Santé 1997;8:3-12
6. Beral V. Implications of new data on radiation cancer risk. In: Proceedings of the thirty second annual meeting of NCRP, 1997
7. Bhatia S, Robinson LL, Oberlin O. Breast cancer after treatment of Hodgkin's disease. N Engl J Med 1996;334:745
8. Boice J, Preston D, Davis FG, Monson RR. Frequent chest Xray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 1991;125:214-22
9. Boice J, Harvey EB, Blettner M, Stovall M, Flannery JT. Cancer in the controlateral breast after radiotherapy for breast cancer. N Engl J Med 1992;326:781-5
10. Boice JD. Implications of new data on radiation cancer risk. Radiation epidemiology: past and present. In: Proceedings of the thirty second annual meeting of NCRP, 1997
11. Busby C, Cato MS. Death rates from leukaemia are higher than expected in areas around nuclear sites in Berkshire and Oxfordshire. BMJ 1997;315:309
12. Cade S. Radiation induced cancer in man. Br J Radiol 1957; 30:393-402
13. Cardis E, Gilbert ES, Carpenter L, Howe G, Kato I, Armstrong BK et al. Effects of low doses and dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res 1995;142:117-32
14. Cosset JM. Maladie de Hodgkin : vers une désescalade thérapeutique. Rev Prat 1993;7:25-30
15. Cosset JM. Secondary cancers after radiotherapy: an introduction. Radioprotection 1997;32:1-241
16. Curtis RE, Boice JD, Stovall M, Bernstein L, Holowaty E, Karjalainen S et al. Relationship of leukemia risk to radiation dose following cancer of the uterine corpus. J Natl Cancer Inst 1994;86:1315-24
17. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socié G, Travis LB et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997;336:897-904
18. Damber L, Larsson LG, Johansson L, Norm T. A cohort study with regard to the risk of haematological malignancies in patients treated with x-rays for benign lesions in the locomotor system. I. Epidemiological analyses. Acta Oncol 1995;34: 713-9
19. De Benedetti VM, Travis LB, Welsh JA, Van Leeuwen FE, Stovall M, Clarke EA et al. p53 mutations in lung cancer following radiation therapy for Hodgkin's disease. Cancer Epidemiol, Biom Prev 1996;5:93-8
20. Degroot LJ. Radiation Associated Thyroid Carcinoma. New York : Ga Stratton, 1977
21. Den Otter W, Merchant TE, Beirerinck D. Exclusion from mammographic screening of women genetically predisposed to breast cancer will probably eliminate mammographically induced breast cancer. Anticancer Res 1993;13:1113-5
22. Den Otter W, Merchant TE, Beijerinxk D. Breast cancer induction due to mammographic screening in hereditarily affected women. Anticancer Res 1996;16:3173-5
23. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzopyrene adducts at lung cancer mutational hotspots in P53. Science 1996;274:430-2
24. Dietrich PY, Bellefqil S, Henry-Amar M, Cosset JM, Hayat M. Linitis plastica after Hodgkin's disease. Lancet 1993;342:57-8
25. Doll R. Hazards of ionising radiation: 100 years of observations on man. Br J Cancer 1995;72:1339-49
26. Doll R, Evans HJ, Darby SC. Paternal exposure not to blame. Nature 1994;367:678-80
27. Epstein RJ, Kelly SA, Cook M, Bateman A, Paddick I, Kam KC et al. Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasms. Radiother Oncol 1996;40:69-74
28. Falchero L, Coiffier B, Guibert B, Souquet PJ, Isaac Pinet S, Trillet-Lenoir V. Malignant mesothelioma of the pleura following radiotherapy of Hodgkin's disease. Bull Cancer 1996; 83:964-8
29. Gardner MJ, Snee MP, Hall AJ, Powell CA, Downes S, Terrell JK. Results of case control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ 1990;300:423-9
30. Hancock SL, Hoppe RT, Horning SJ. Intercurrent death after Hodgkins disease therapy in radiotherapy and adjuvant MOPP trials. Annals International Medecine 1988;109:183-9
31. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599
32. Hankey BF, Curtis RE, Naughton JD, Boice JD, Flannery JT. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst 1983;70:797-804
33. Hattchouel JM, Laplanche A, Hill C. Mortalité par cancer autour d'installations nucléaires françaises. In: Questions en santé publique. Paris : Éd Inserm, 1995
34. Henry-Amar M. Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease. NCI Monogr 1988;6:65-72
35. Henry-Amar M, Somers R. Long-term survival in early stages Hodgkin's disease; the EORTC experience. In: Treatment Strategy in Hodgkin's Disease. Paris : éd Inserm, John Libbey Éd, 1990
36. Henry-Amar M. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's disease. Ann Oncol 1992;3:S117-S28
37. Henry-Amar M, Joly F. Late complications after Hodgkin's disease. Ann Oncol 1996;7:S115-S6
38. Hill C, Laplanche A. Mortalité autour d'installations nucléaires françaises. Paris : Éd Inserm, Douin Éd, 1992
39. Hubert D, Lallemant J. Risques de cancers chez les travailleurs de l'industrie nucléaire. Bull Cancer 1992;79:5-23
40. IARC. Direct estimates of cancer mortality due to low doses of ionising radiation: an international study. Lancet 1994;344: 1039-43
41. Inskip H. Childhood leukaemia near nuclear sites re-examined. Lancet 1997;349:969-70
42. Ivanov VK, Tsyb AF, Gorsky AI, Maksyutov MA, Rastopochin EM, Konogorov AP et al. Leukaemia and thyroid cancer in emergency workers of the Chernobyl accident: estimation of radiation risks (1994-1995). Radiat Environ Biophys 1997;36:9-16
43. Jankowski J. The consequences of the Chernobyl accident one decade after the disaster. Int J Occup Med Env Health 1996;9:365-74
44. Kaldor JM, Day NE, Bell J. Lung cancer following Hodgkin's disease: a case control study. Int J Cancer 1992;52:677-81
45. Kelly CA, Wang XY, Chu JC, Harsell WF. Dose to controlateral breast: a comparison of four primary breast irradiation techniques. Int J Radiat Oncol Biol Phys 1996;35:727-32
46. Kerber RA, Till JE, Simon SL. A cohort study of thyroid disease in relation to fllout from nuclear weapons testing. JAMA 1993;270:2076-82
47. Kinlen LJ. Infection and childhood leukaemia near nuclear sites. Lancet 1988;349:1702
48. Kuttesch JF, Wexler LH, Marcus RB, Fairclough D, Weaver-McClure L, White MML et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996;14:2818-25
49. Lacassagne A, Grigouroff G. Effets cancérogènes des rayonnements ionisants. In : Radiobiologie appliquée, vol II. Paris : Gauthier-Villars Éd, 1966;584-646
50. Law J. Cancers detected and induced in mammographic screening: new screening schedules and younger women with family history. Br J Cancer 1997;70:62-9
51. Little MP, Charles MW, Wakeford R. A review of the risks of leukaemia in relation to parental pre-conception exposure to radiation. Health Phys 1995;68:299-310
52. Lubin JH, Boice JD. Radon and lung cancer risk. A joint analysis of eleven underground miner studies. Bethesda : NIH Publication 94-3644 National Institute of Health, 1994
53. Mabuchi K, Soda M, Ron E. Cancer incidence in atomic bomb survivors. Part I. Use of tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res 1994;137:81-516
54. March HC. Leukaemia in radiologists. Radiology 1944;43:275-8
55. Mattsson A, Ruden BI, Palmgren J, Rutqvist LE. Dose and time response for breast cancer risk after radiation. Br J Cancer 1995;72:1054-61
56. McLaughlin JR, Clarke EA, Nishri ED, Anderson TW. Childhood leukemia in the vicinity of Canadian nuclear facilities. Cancer & Causes & Control 1993;4:51-8
57. Mettler FA, Upton AC, Kelsey CA. Benefits versus risks from mammography: a critical reassessment. Cancer 1996;77:903-9
58. Modan B, Baidatz D, Mart H. Radiation-induced head and neck tumours. Lancet 1974;1:277-9
59. Neugut AL, Murray T, Santos J, Amols H, Hayes MK, Flannery JT et al. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer 1994;73:1615-20
60. Neugut AI, Ahsan H, Robinson E, Ennis RD. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 1997;79:1600-4
61. Parker R. Radiation-induced cancer as a factor in clinical decision making. Int J Radiat Oncol Biol Phys 1990;18:993-1000
62. Pierce DA, Shimizu Y, Preston DL. Studies of the mortality of atomic bomb survivors. Report 12, Part 1. Cancer: 1950-1990. Radial Res 1996;146:1-27
63. Pobel D, Viel JF. Case-control study of leukaemia among young people near la Hague nuclear reprocessing plant: the environmental hypothesis revisited. BMJ 1997;314:101-6
64. Preston DL, Kusumi M, Tomonaga M, Izumi S, Ron E, Kuramoto A et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma. 1950-1987. Radial Res 1994;137:S68-S97
65. Ron E, Modan B, Boice JD. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988; 319:1033-9
66. Ron E, Preston DL, Mabuchi K, Thompson DE, Soda M. Cancer incidence in atomic bomb survivors. Part IV. Comparison cancer incidence and mortality. Radiat Res 1994;137:S98-112
67. Rowland RE, Stehney AF, Lucas HF. Dose response relationship for female radium dial workers. Radiat Res 1978; 76:368-83
68. Salloum E, Doria R, Schubert W. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 1996;14:2435-43
69. Shimizu Y, Kato H, Schull WJ. Studies of the mortality of A-Bomb survivors. 1950-1985: cancer mortality based on the recently revised doses (DS86). Radiat Res 1990;121:120-41
70. Shintani T, Hayakawa N, Kamada N. High incidence of meningioma in survivors of Hiroshima. Lancet 1997;349:1369
71. Simon SL, Till JE, Lloyd RD, Kerbert RL, Thomas DC, Preston-Martin S et al. The Utah leukaemia case-control study: dosimetry methodology and results. Health Phys 1995;68: 460-71
72. Slotman BJ, Van Hattum AH, Meyer S. Angiosarcoma of the breast following conserving treatment for breast cancer. Eur J Cancer 1994;30A:416-7
73. Smith P, Doll R. Mortality among patients with ankylosing spondylitis after a single treatment course with X-rays. Br J Cancer 1982;284:449-60
74. Sole JM, Gueda F, Matias-Guiu X. Long-term risk of sarcoma following radiation treatment for breast cancer. Oncology Reports 1996;3:397-9
75. Stevens W. Leukaemia in Utah and radioactive fallout from the Nevada test site. A case-control study. JAMA 1990; 264:585-91
76. Swerdlow AJ, Barber JA, Horwich A, Cunningham D, Milan S, Omar RZ. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer 1997;75:116-23
77. Thompson DE, Mabuychi K, Ron E, Soda M, Tokunaga M, Ochikubo S et al. Cancer incidence in atomic bomb survivors. Part II. Solid tumors, 1958-1987. Radiat Res 1994;137: S17-S67
78. Tubiana M. Cancers par nuisances thérapeutiques : cancers et radiothérapie. Bull Cancer 1983;70:47-54
79. Tucker M, Jones P, Boice JD, Robison LL, Stone BJ, Stovall M et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 1991;51:2885-8
80. Unscear. Screening younger women at risk for breast cancer. NCI Monograph 1994;16:55-60
81. Unscear. Sources and effects of ionising radiation. United Nations Scientific Committee on the Effects of Atomic Radiation. Report to the General Assembly, 1994
82. Van Leeuwen FE, Klokman WJ, Stovall M. Role of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 1995;87:1530
83. Viel JF, Richardson S, Danel P, Boutard P, Malet M, Barrelier P et al. Childhood leukaemia incidence in the vicinity of la Hague nuclear-waste reprocessing facility (France). Cancer & Causes & Control 1993;4:341-3
84. Viel JF, Pobel D, Carre A. Incidence of leukaemia in young people aroung the la Hague nuclear waste reprocessing plant: a sensitivity analysis. Stat Med 1995;14;2459-72
85. Wijnmaalen A, Vang Ooijen B, Van Geel BN. Angiosarcoma of the breast following lymphectomy axillary lymph node dissection and radiotherapy for primary breast cancer: case reports and a review of the literature. Int J Radiat Oncol Biol Phys 1993;26:135-9
86. Wing S, Shy CM, Wood JL. Mortality among workers at Oak Ridge National Laboratory. Evidence of radiation effects in follow-up through. JAMA 1984;265:1397-402
87. Zucali R, Merson M, Plascucci M. Soft tissue sarcoma of the breast after conservative surgery and irradiation for early mammary cancer. Radiother Oncol 1994;30:271-3